- Home
- IMVT vs PSNY Comparison
IMVT vs PSNY Comparison
Compare IMVT & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- PSNY
- Stock Information
- Founded
- IMVT 2018
- PSNY 2017
- Country
- IMVT United States
- PSNY Sweden
- Employees
- IMVT N/A
- PSNY N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- PSNY Auto Manufacturing
- Sector
- IMVT Health Care
- PSNY Consumer Discretionary
- Exchange
- IMVT Nasdaq
- PSNY Nasdaq
- Market Cap
- IMVT 2.7B
- PSNY 2.3B
- IPO Year
- IMVT N/A
- PSNY N/A
- Fundamental
- Price
- IMVT $16.00
- PSNY $0.91
- Analyst Decision
- IMVT Buy
- PSNY Hold
- Analyst Count
- IMVT 10
- PSNY 2
- Target Price
- IMVT $33.38
- PSNY $1.25
- AVG Volume (30 Days)
- IMVT 1.7M
- PSNY 3.3M
- Earning Date
- IMVT 11-06-2025
- PSNY 09-03-2025
- Dividend Yield
- IMVT N/A
- PSNY N/A
- EPS Growth
- IMVT N/A
- PSNY N/A
- EPS
- IMVT N/A
- PSNY N/A
- Revenue
- IMVT N/A
- PSNY $2,547,619,000.00
- Revenue This Year
- IMVT N/A
- PSNY $48.90
- Revenue Next Year
- IMVT N/A
- PSNY $44.64
- P/E Ratio
- IMVT N/A
- PSNY N/A
- Revenue Growth
- IMVT N/A
- PSNY 24.82
- 52 Week Low
- IMVT $12.72
- PSNY $0.84
- 52 Week High
- IMVT $32.10
- PSNY $1.68
- Technical
- Relative Strength Index (RSI)
- IMVT 50.79
- PSNY 36.34
- Support Level
- IMVT $15.81
- PSNY $0.92
- Resistance Level
- IMVT $17.15
- PSNY $0.98
- Average True Range (ATR)
- IMVT 0.73
- PSNY 0.03
- MACD
- IMVT 0.10
- PSNY -0.00
- Stochastic Oscillator
- IMVT 57.98
- PSNY 0.73
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.